Genomics Reporting Implementation Guide, published by HL7 International / Clinical Genomics. This guide is not an authorized publication; it is the continuous build for version 3.0.1-SNAPSHOT built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/genomics-reporting/ and changes regularly. See the Directory of published versions
Generated Narrative: Observation
Resource Observation "EGFR-L858R-therapuDrug1"
Profile: Therapeutic Implication
status: final
category: Laboratory (Observation Category Codes#laboratory), Genetics (diagnosticServiceSectionId#GE)
code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)
subject: Patient/somaticPatient " HAMSBURG"
effective: 2023-02-01
performer: Practitioner/pathologistPractitioner " DOLIN"
derivedFrom: Observation/EGFR-L858R-var
component
code: Therapeutic Implication (To Be Determined Codes#therapeutic-implication)
value: Responsive (LOINC#LA6677-4)
component
Related Artifact for Observation component:
code: Level of evidence (LOINC#93044-6)
value: Tier I - Level A ()
component
code: Prob assoc phenotype (LOINC#81259-4)
value: Non-small cell lung cancer (SNOMED CT#254637007 "Non-small cell lung cancer (disorder)")
component
Related Artifact for Observation component:
code: Medication assessed (LOINC#51963-7)
value: Gefitinib ()
component
Related Artifact for Observation component:
code: Conclusion Text (To Be Determined Codes#conclusion-string)
value: Non-small cell lung cancer with EGFR L858R mutation is sensitive to gefitinib